Propoxyphene and Metabolite, Urine, Quantitative
2010468
Ordering Recommendation
Preferred test to follow-up presumptive results. For general screening, Propoxyphene, Urine Screen with Reflex to Quantitation (2012269) is preferred.
Mnemonic
PPXY UR
Methodology
Quantitative Liquid Chromatography-Tandem Mass Spectrometry
Performed
Mon
Reported
1-8 days
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
Specimen Required
- Patient Preparation
- Collect
- Random urine.
- Specimen Preparation
- Transfer 1 mL with no additives or preservatives urine to an ARUP Standard Transport Tube. (Min: 0.5 mL)
- Storage/Transport Temperature
- Room temperature.
- Unacceptable Conditions
- Remarks
- Stability
- Ambient: 1 week; Refrigerated: 1 month; Frozen: 3 years (Avoid repeated freeze/thaw cycles)
Reference Interval
Effective August 17, 2015
| Drugs Covered | Cutoff Concentrations |
| Propoxyphene | 10 ng/mL |
| Norpropoxyphene (qualitative only) | 10 ng/mL |
Interpretive Data
Methodology: Quantitative Liquid Chromatography-Tandem Mass Spectrometry
Positive cutoff: 10 ng/mL.
For medical purposes only; not valid for forensic use.
The absence of expected drug(s) and/or drug metabolite(s) may indicate non-compliance, inappropriate timing of specimen collection relative to drug administration, poor drug absorption, diluted/adulterated urine, or limitations of testing. The concentration value must be greater than or equal to the cutoff to be reported as positive. Norpropoxyphene is reported as qualitative only. Interpretive questions should be directed to the laboratory.
Positive cutoff: 10 ng/mL.
For medical purposes only; not valid for forensic use.
The absence of expected drug(s) and/or drug metabolite(s) may indicate non-compliance, inappropriate timing of specimen collection relative to drug administration, poor drug absorption, diluted/adulterated urine, or limitations of testing. The concentration value must be greater than or equal to the cutoff to be reported as positive. Norpropoxyphene is reported as qualitative only. Interpretive questions should be directed to the laboratory.
Compliance Statement B: For laboratory developed tests not using a RUO kit, and for FDA approved, cleared or 510(k) exempt assays with alterations. This test was developed and its performance characteristics determined by ARUP Laboratories. The U. S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.
Note
Hotline History
N/A
CPT Code(s)
80367 (Alt code: G0480)
Components
| Component Test Code* | Component Chart Name | LOINC |
|---|---|---|
| 2010470 | Propoxyphene, Urn, Quant | 3545-1 |
| 2010471 | Norpropoxyphene, Urn, Qual | 19635-2 |
Aliases